Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative Colitis
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Aminosalicylic Acid
- Colitis Ulcerative
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
This is a randomized, double-blind, controlled trial in which patients with long-standing clinically inactive UC receiving ASA for maintenance of remission will be randomized to either continue 5-ASA or to receive an equivalent placebo for 12 months. The primary endpoint is clinical relapse at 12 mo...
This is a randomized, double-blind, controlled trial in which patients with long-standing clinically inactive UC receiving ASA for maintenance of remission will be randomized to either continue 5-ASA or to receive an equivalent placebo for 12 months. The primary endpoint is clinical relapse at 12 months.
Tracking Information
- NCT #
- NCT02537210
- Collaborators
- Queen Elizabeth Hospital, Hong Kong
- Alice Ho Miu Ling Nethersole Hospital
- Tseung Kwan O Hospital, Hong Kong
- Investigators
- Principal Investigator: Siew Ng, PhD Chinese University of Hong Kong
Get Well Soon